发明名称 |
USE OF TGF-ß ANTAGONISTS TO TREAT INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |
摘要 |
The disclosure relates to methods of treating an infant at risk of developing bronchopulmonary dysplasia, including premature infants, by administering a TGF-ß antagonist during the perinatal period, including the prenatal period and/or the postnatal period. For administration during the prenatal period, the TGF-ß antagonist can be administered either directly to the infant in utero, or indirectly by administration to the mother. |
申请公布号 |
WO2008060371(A8) |
申请公布日期 |
2008.07.10 |
申请号 |
WO2007US21234 |
申请日期 |
2007.10.03 |
申请人 |
GENZYME CORPORATION;STREISAND, JAMES, B.;ROBERTS, JESSE, D., JR. |
发明人 |
STREISAND, JAMES, B.;ROBERTS, JESSE, D., JR. |
分类号 |
A61K39/395;A61P11/00;C07K16/22 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|